Home » Topics » Regulatory » Patents

Patents
RSS

Neuroprotective agents based on enzyme inhibition prepared at P&U

June 11, 1998

Pfizer team reveals heterobicyclic CRF antagonists

June 11, 1998

Novel rapamycin derivatives patented by AHP

June 11, 1998

Warner-Lambert team describes preferential inhibitors of MMP-2 and MMP-3

June 11, 1998

New antiallergic and antiinflammatory compounds developed by Astra researchers

June 11, 1998

Pfizer discloses indazole inhibitors of PDE and TNF production

June 11, 1998

Crambescidin 816, an antiviral and antitumor agent from a marine sponge

June 10, 1998

AHP reports dopamine autoreceptor agonists with antipsychotic potential

June 10, 1998

Antitumor, antifungal cryptophycins developed by U.S. pharmaceutical/academic team

June 9, 1998

Byk Gulden patents another series of thiazole PDE IV inhibitors

June 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.